Interestingly, the antitumor effect of Csn-B was also reported in BC based on the alleviation of the NR4A1–PPARγ interplay and PPARγ-mediated NR4A1 degradation to augment NR4A1 function25. The gene discussed is PPARG; the disease is breast cancer.